Quanterix (QTRX) Set to Post Quarterly Earnings on Monday

Quanterix (NASDAQ:QTRX) is anticipated to announce its Q3 2026 results before the market opens on Monday, November 9th. Analysts expect Quanterix to announce earnings of ($0.42) per share and revenue of $33.85 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Monday, November 9, 2026 at 8:30 AM ET.

Quanterix (NASDAQ:QTRX) last released its quarterly earnings results on Monday, August 10th. The company reported ($1.04) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.63). Quanterix had a negative return on equity of 26.09% and a negative net margin of 80.25%. The company had revenue of $32.91 million for the quarter, compared to analysts’ expectations of $37.48 million.

Quanterix Price Performance

Shares of NASDAQ QTRX opened at $2.90 on Monday. The company has a market cap of $137.15 million, a PE ratio of -1.10 and a beta of 1.02. The stock has a fifty day moving average price of $2.99 and a 200 day moving average price of $3.91. Quanterix has a 1-year low of $2.15 and a 1-year high of $8.77.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on QTRX shares. TD Cowen increased their price target on shares of Quanterix from $3.00 to $3.50 and gave the stock a “hold” rating in a report on Tuesday, October 13th. Canaccord Genuity Group dropped their price objective on Quanterix from $4.00 to $3.00 and set a “hold” rating on the stock in a report on Monday, August 17th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Quanterix in a research report on Friday, August 7th. Finally, Wall Street Zen raised Quanterix from a “sell” rating to a “hold” rating in a report on Saturday, September 19th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $3.25.

Quanterix Company Profile

Quanterix Corporation (NASDAQ:QTRX) is a life sciences company that develops ultra-sensitive digital immunoassay technologies for detecting and measuring biomarkers in blood and other biological samples. Its platform is designed to identify proteins and other molecules at very low concentrations, supporting research into disease biology, diagnosis, treatment response and drug development.

The company’s principal technology, Simoa, uses digital detection methods to improve the sensitivity of immunoassays.